Correlation Between GeneBioTech and Medy Tox

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneBioTech and Medy Tox at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneBioTech and Medy Tox into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneBioTech Co and Medy Tox, you can compare the effects of market volatilities on GeneBioTech and Medy Tox and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneBioTech with a short position of Medy Tox. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneBioTech and Medy Tox.

Diversification Opportunities for GeneBioTech and Medy Tox

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GeneBioTech and Medy is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding GeneBioTech Co and Medy Tox in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medy Tox and GeneBioTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneBioTech Co are associated (or correlated) with Medy Tox. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medy Tox has no effect on the direction of GeneBioTech i.e., GeneBioTech and Medy Tox go up and down completely randomly.

Pair Corralation between GeneBioTech and Medy Tox

Assuming the 90 days trading horizon GeneBioTech Co is expected to generate 1.27 times more return on investment than Medy Tox. However, GeneBioTech is 1.27 times more volatile than Medy Tox. It trades about 0.12 of its potential returns per unit of risk. Medy Tox is currently generating about -0.09 per unit of risk. If you would invest  335,000  in GeneBioTech Co on October 15, 2024 and sell it today you would earn a total of  12,500  from holding GeneBioTech Co or generate 3.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GeneBioTech Co  vs.  Medy Tox

 Performance 
       Timeline  
GeneBioTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneBioTech Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, GeneBioTech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Medy Tox 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medy Tox has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

GeneBioTech and Medy Tox Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneBioTech and Medy Tox

The main advantage of trading using opposite GeneBioTech and Medy Tox positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneBioTech position performs unexpectedly, Medy Tox can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will offset losses from the drop in Medy Tox's long position.
The idea behind GeneBioTech Co and Medy Tox pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories